SlideShare a Scribd company logo
Beyond the Business Plan ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Presentation starts on next page For more information: Yali Friedman, Ph.D. [email_address] www.BuildingBiotechnology.com
Beyond the Business Plan Managing unexpected risks in biotechnology business development Yali Friedman, Ph.D. – info@thinkbiotech.com
Beyond the Business Plan ,[object Object],[object Object],[object Object]
Business risks ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Freedom to operate ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],BUILDING BIOTECHNOLOGY  Chp 7, p. 267
Amgen v. Transkaryotic:  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],BUILDING BIOTECHNOLOGY  p. 120
Monsanto hit by submarine patent ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],BUILDING BIOTECHNOLOGY  p. 126
Manufacturing problems ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],BUILDING BIOTECHNOLOGY  pp. 202, 346-7, 161
Lessons ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
If you build it, they might not come ,[object Object],[object Object],[object Object],[object Object],[object Object]
Evacyte: Classic technology push ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],BUILDING BIOTECHNOLOGY  pp. 264-265
Calgene’s Flavr Savr tomato ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],BUILDING BIOTECHNOLOGY  p. 326
Path to development ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Market launch ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Why do companies aim for empty markets? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Estimating market size ,[object Object],[object Object],[object Object],[object Object],[object Object],BUILDING BIOTECHNOLOGY  pp  235-239, 273-276
Resolving valuation disagreements ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],BUILDING BIOTECHNOLOGY  p 304
Low estimates can be detrimental ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],BUILDING BIOTECHNOLOGY  p 275
Lessons ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Off-label use ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],BUILDING BIOTECHNOLOGY  pp 148-150
Fen-Phen: Yes, you can be too popular ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],BUILDING BIOTECHNOLOGY  p 150
Fentora: Don’t buy our drug ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],BUILDING BIOTECHNOLOGY  p 148
Avastin: Controlling off-label use ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],BUILDING BIOTECHNOLOGY  p 282
Lessons ,[object Object],[object Object]
Shareholder / board activism BUILDING BIOTECHNOLOGY  pp. 193-197
Dyadic:  Et tu Brute ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
Shareholder letter
Founder regains control … of what?
MedImmune: Shareholder activism ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],BUILDING BIOTECHNOLOGY  pp. 195
With partners like these, who needs competitors ,[object Object],[object Object],[object Object],[object Object],[object Object]
Suing the Red Cross ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],BUILDING BIOTECHNOLOGY  p 131
IP disputes with major backers ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],BUILDING BIOTECHNOLOGY  p 186
Nektar: Running with the big dogs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],BUILDING BIOTECHNOLOGY  pp.250-251, 308
Lessons ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
The business plan is but the beginning ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Yali Friedman – info@thinkbiotech.com
Building Biotechnology on Facebook ,[object Object],[object Object],[object Object],[object Object],[object Object]

More Related Content

What's hot

Investor presentation april_2012-1
Investor presentation april_2012-1Investor presentation april_2012-1
Investor presentation april_2012-1
rymankoly
 
Investor presentation april_2012
Investor presentation april_2012Investor presentation april_2012
Investor presentation april_2012
rymankoly
 
AMI August Investor Presentation
AMI  August Investor PresentationAMI  August Investor Presentation
AMI August Investor Presentation
RedChip Companies, Inc.
 
BIOSIMILARS - Regulation and Market Trends
BIOSIMILARS - Regulation and Market Trends    BIOSIMILARS - Regulation and Market Trends
BIOSIMILARS - Regulation and Market Trends
Joseph Pategou
 
Innovation and entrepreneurship in biotechnology an intl perspective - d. h...
Innovation and entrepreneurship in biotechnology   an intl perspective - d. h...Innovation and entrepreneurship in biotechnology   an intl perspective - d. h...
Innovation and entrepreneurship in biotechnology an intl perspective - d. h...
sanguru1977
 
Imugene corporate deck jan18
Imugene corporate deck jan18Imugene corporate deck jan18
Imugene corporate deck jan18
tttinor
 
Leading Molecules to Market - An overview on licensing
 Leading Molecules to Market - An overview on licensing Leading Molecules to Market - An overview on licensing
Leading Molecules to Market - An overview on licensing
BananaIP Counsels
 
Imugene (ASX: IMU)
Imugene (ASX: IMU)Imugene (ASX: IMU)
Imugene (ASX: IMU)
RedChip Companies, Inc.
 
PharmAust: A Leader In Pharmaceutical Research & Discovery
PharmAust: A Leader In Pharmaceutical Research & DiscoveryPharmAust: A Leader In Pharmaceutical Research & Discovery
PharmAust: A Leader In Pharmaceutical Research & Discovery
RedChip Companies, Inc.
 
Merck: Global Health and Access to Medicines
Merck: Global Health and Access to  MedicinesMerck: Global Health and Access to  Medicines
Merck: Global Health and Access to Medicines
Tony Sebastian
 
Investor presentation _-_march_2012_2
Investor presentation _-_march_2012_2Investor presentation _-_march_2012_2
Investor presentation _-_march_2012_2
rymankoly
 
RiskAssessmentCBIFalcon25June2012
RiskAssessmentCBIFalcon25June2012RiskAssessmentCBIFalcon25June2012
RiskAssessmentCBIFalcon25June2012Robert Falcon
 
AIS Investor presentation january 2011
AIS Investor presentation january 2011AIS Investor presentation january 2011
AIS Investor presentation january 2011
rymankoly
 
Importance Of Patents In The Life Sciences Industry
Importance Of Patents In The Life Sciences IndustryImportance Of Patents In The Life Sciences Industry
Importance Of Patents In The Life Sciences Industrybatane
 

What's hot (15)

Investor presentation april_2012-1
Investor presentation april_2012-1Investor presentation april_2012-1
Investor presentation april_2012-1
 
Investor presentation april_2012
Investor presentation april_2012Investor presentation april_2012
Investor presentation april_2012
 
AMI August Investor Presentation
AMI  August Investor PresentationAMI  August Investor Presentation
AMI August Investor Presentation
 
BIOSIMILARS - Regulation and Market Trends
BIOSIMILARS - Regulation and Market Trends    BIOSIMILARS - Regulation and Market Trends
BIOSIMILARS - Regulation and Market Trends
 
Innovation and entrepreneurship in biotechnology an intl perspective - d. h...
Innovation and entrepreneurship in biotechnology   an intl perspective - d. h...Innovation and entrepreneurship in biotechnology   an intl perspective - d. h...
Innovation and entrepreneurship in biotechnology an intl perspective - d. h...
 
Imugene corporate deck jan18
Imugene corporate deck jan18Imugene corporate deck jan18
Imugene corporate deck jan18
 
Leading Molecules to Market - An overview on licensing
 Leading Molecules to Market - An overview on licensing Leading Molecules to Market - An overview on licensing
Leading Molecules to Market - An overview on licensing
 
Imugene (ASX: IMU)
Imugene (ASX: IMU)Imugene (ASX: IMU)
Imugene (ASX: IMU)
 
PharmAust: A Leader In Pharmaceutical Research & Discovery
PharmAust: A Leader In Pharmaceutical Research & DiscoveryPharmAust: A Leader In Pharmaceutical Research & Discovery
PharmAust: A Leader In Pharmaceutical Research & Discovery
 
PTX
PTXPTX
PTX
 
Merck: Global Health and Access to Medicines
Merck: Global Health and Access to  MedicinesMerck: Global Health and Access to  Medicines
Merck: Global Health and Access to Medicines
 
Investor presentation _-_march_2012_2
Investor presentation _-_march_2012_2Investor presentation _-_march_2012_2
Investor presentation _-_march_2012_2
 
RiskAssessmentCBIFalcon25June2012
RiskAssessmentCBIFalcon25June2012RiskAssessmentCBIFalcon25June2012
RiskAssessmentCBIFalcon25June2012
 
AIS Investor presentation january 2011
AIS Investor presentation january 2011AIS Investor presentation january 2011
AIS Investor presentation january 2011
 
Importance Of Patents In The Life Sciences Industry
Importance Of Patents In The Life Sciences IndustryImportance Of Patents In The Life Sciences Industry
Importance Of Patents In The Life Sciences Industry
 

Viewers also liked

Business plan
Business planBusiness plan
Business planStudent
 
Economic Development Lands Planning Pilot Project
Economic Development Lands Planning Pilot ProjectEconomic Development Lands Planning Pilot Project
Economic Development Lands Planning Pilot Projecticablearning
 
Leading Virtual Teams In The Pharma And Biotech World.Ppt
Leading Virtual Teams In The Pharma And Biotech World.PptLeading Virtual Teams In The Pharma And Biotech World.Ppt
Leading Virtual Teams In The Pharma And Biotech World.Ppt
lyndamcdermott
 
AutoDCR
AutoDCRAutoDCR
AutoDCR
SoftTechLive
 
Rivergreen Residences Presentation
Rivergreen Residences PresentationRivergreen Residences Presentation
Rivergreen Residences Presentation
John Michael Pacheo
 
Autodcr level1
Autodcr level1Autodcr level1
Autodcr level1
SoftTechLive
 
Perak biotechnology business plan
Perak biotechnology business planPerak biotechnology business plan
Perak biotechnology business planjongos89
 
Partner Training: Business Plan Development
Partner Training: Business Plan DevelopmentPartner Training: Business Plan Development
Partner Training: Business Plan Development
BizcentralUSA
 
BioEntrepreneurship: The Business of Biotech
BioEntrepreneurship: The Business of BiotechBioEntrepreneurship: The Business of Biotech
BioEntrepreneurship: The Business of Biotech
MaRS Discovery District
 
Project Plan Development - A FlackVentures Training Example
Project Plan Development - A FlackVentures Training ExampleProject Plan Development - A FlackVentures Training Example
Project Plan Development - A FlackVentures Training Example
Kate Pynn
 
Business Plan on a Bio-Tech product
Business Plan on a Bio-Tech productBusiness Plan on a Bio-Tech product
Business Plan on a Bio-Tech product
Tarkeshwar Singh
 
Genetically modified foods
Genetically modified foodsGenetically modified foods
Genetically modified foods14nieman
 
Individual Development Plan For Peter Stinson Draft March 2008
Individual Development Plan For  Peter Stinson   Draft   March 2008Individual Development Plan For  Peter Stinson   Draft   March 2008
Individual Development Plan For Peter Stinson Draft March 2008Peter Stinson
 
Building Your Customer Development Plan
Building Your Customer Development PlanBuilding Your Customer Development Plan
Building Your Customer Development PlanCindy Alvarez
 
Example Business Plan Presentation - Steamboat Leleh
Example Business Plan Presentation - Steamboat Leleh Example Business Plan Presentation - Steamboat Leleh
Example Business Plan Presentation - Steamboat Leleh
normaisarah71
 
Business Plan
Business PlanBusiness Plan
Business Plan
Akhil Gupta
 

Viewers also liked (17)

Business plan
Business planBusiness plan
Business plan
 
Economic Development Lands Planning Pilot Project
Economic Development Lands Planning Pilot ProjectEconomic Development Lands Planning Pilot Project
Economic Development Lands Planning Pilot Project
 
Leading Virtual Teams In The Pharma And Biotech World.Ppt
Leading Virtual Teams In The Pharma And Biotech World.PptLeading Virtual Teams In The Pharma And Biotech World.Ppt
Leading Virtual Teams In The Pharma And Biotech World.Ppt
 
AutoDCR
AutoDCRAutoDCR
AutoDCR
 
Rivergreen Residences Presentation
Rivergreen Residences PresentationRivergreen Residences Presentation
Rivergreen Residences Presentation
 
Autodcr level1
Autodcr level1Autodcr level1
Autodcr level1
 
Perak biotechnology business plan
Perak biotechnology business planPerak biotechnology business plan
Perak biotechnology business plan
 
Buisiness Training Plan 2015
Buisiness Training Plan 2015Buisiness Training Plan 2015
Buisiness Training Plan 2015
 
Partner Training: Business Plan Development
Partner Training: Business Plan DevelopmentPartner Training: Business Plan Development
Partner Training: Business Plan Development
 
BioEntrepreneurship: The Business of Biotech
BioEntrepreneurship: The Business of BiotechBioEntrepreneurship: The Business of Biotech
BioEntrepreneurship: The Business of Biotech
 
Project Plan Development - A FlackVentures Training Example
Project Plan Development - A FlackVentures Training ExampleProject Plan Development - A FlackVentures Training Example
Project Plan Development - A FlackVentures Training Example
 
Business Plan on a Bio-Tech product
Business Plan on a Bio-Tech productBusiness Plan on a Bio-Tech product
Business Plan on a Bio-Tech product
 
Genetically modified foods
Genetically modified foodsGenetically modified foods
Genetically modified foods
 
Individual Development Plan For Peter Stinson Draft March 2008
Individual Development Plan For  Peter Stinson   Draft   March 2008Individual Development Plan For  Peter Stinson   Draft   March 2008
Individual Development Plan For Peter Stinson Draft March 2008
 
Building Your Customer Development Plan
Building Your Customer Development PlanBuilding Your Customer Development Plan
Building Your Customer Development Plan
 
Example Business Plan Presentation - Steamboat Leleh
Example Business Plan Presentation - Steamboat Leleh Example Business Plan Presentation - Steamboat Leleh
Example Business Plan Presentation - Steamboat Leleh
 
Business Plan
Business PlanBusiness Plan
Business Plan
 

Similar to Beyond the Business Plan - Managing unexpected risks in biotechnology business development

Functional Overview of the Biotechnology Industry
Functional Overview of the Biotechnology IndustryFunctional Overview of the Biotechnology Industry
Functional Overview of the Biotechnology Industry
thinkBiotech
 
Eli Lilly Global Strategy
Eli Lilly Global StrategyEli Lilly Global Strategy
Eli Lilly Global Strategy
guest90d5a
 
Biotechnology 1
Biotechnology 1Biotechnology 1
Biotechnology 1sokraturk
 
Dendreon Presentation
Dendreon PresentationDendreon Presentation
Dendreon Presentation
afa4
 
Dendreon Strategic Analysis
Dendreon Strategic AnalysisDendreon Strategic Analysis
Dendreon Strategic Analysis
afa4
 
Roche & Alexion M&A Simulation
Roche & Alexion M&A SimulationRoche & Alexion M&A Simulation
Roche & Alexion M&A Simulation
Aurore Cassin
 
Bio Pharm Collaborations 9 09
Bio Pharm Collaborations 9 09Bio Pharm Collaborations 9 09
Bio Pharm Collaborations 9 09
thess1121
 
The Role of clinical Research in Pharmaceuticals Industry
The Role of clinical Research in Pharmaceuticals IndustryThe Role of clinical Research in Pharmaceuticals Industry
The Role of clinical Research in Pharmaceuticals Industry
Varsha Chauhan
 
New England Compounding Center and Microbial Contamination ASQ Presentation
New England Compounding Center and Microbial Contamination ASQ PresentationNew England Compounding Center and Microbial Contamination ASQ Presentation
New England Compounding Center and Microbial Contamination ASQ Presentation
Microbiological Environments Inc.
 
Eyf webinar sepa career fair 2010
Eyf webinar sepa career fair 2010Eyf webinar sepa career fair 2010
Eyf webinar sepa career fair 2010elliecantor
 
pharmaceutical-industry-r-d-an-inside-out-look.ppt
pharmaceutical-industry-r-d-an-inside-out-look.pptpharmaceutical-industry-r-d-an-inside-out-look.ppt
pharmaceutical-industry-r-d-an-inside-out-look.ppt
Asaduddin Abdullah
 
Pharmaceutical Industry - Business Perspectives for IT Teams
Pharmaceutical Industry - Business Perspectives for IT TeamsPharmaceutical Industry - Business Perspectives for IT Teams
Pharmaceutical Industry - Business Perspectives for IT TeamsSatheesh Kadiam
 
Pharma Focus Asia Issue 21
Pharma Focus Asia Issue 21Pharma Focus Asia Issue 21
Pharma Focus Asia Issue 21
yahyasultan
 
Genentech
GenentechGenentech
BioEntrepreneurship: Life Science Business Models
BioEntrepreneurship: Life Science Business ModelsBioEntrepreneurship: Life Science Business Models
BioEntrepreneurship: Life Science Business Models
MaRS Discovery District
 
Focus On Brazil 1.7
Focus On Brazil 1.7Focus On Brazil 1.7
Focus On Brazil 1.7Jay Nadkarni
 
Focus On Brazil 1.8
Focus On Brazil 1.8Focus On Brazil 1.8
Focus On Brazil 1.8Jay Nadkarni
 
Eli Lilly and company - Drug Development Strategy
Eli Lilly and company - Drug Development StrategyEli Lilly and company - Drug Development Strategy
Eli Lilly and company - Drug Development Strategy
Mohammad Mohtashim
 
Aiden hollis hif presentation berkeley
Aiden hollis   hif presentation berkeleyAiden hollis   hif presentation berkeley
Aiden hollis hif presentation berkeleyOpen Science Summit
 
What's In An Idea-Chanda-UofT Life Science Coach
What's In An Idea-Chanda-UofT Life Science CoachWhat's In An Idea-Chanda-UofT Life Science Coach
What's In An Idea-Chanda-UofT Life Science Coach
Debra A. Chanda
 

Similar to Beyond the Business Plan - Managing unexpected risks in biotechnology business development (20)

Functional Overview of the Biotechnology Industry
Functional Overview of the Biotechnology IndustryFunctional Overview of the Biotechnology Industry
Functional Overview of the Biotechnology Industry
 
Eli Lilly Global Strategy
Eli Lilly Global StrategyEli Lilly Global Strategy
Eli Lilly Global Strategy
 
Biotechnology 1
Biotechnology 1Biotechnology 1
Biotechnology 1
 
Dendreon Presentation
Dendreon PresentationDendreon Presentation
Dendreon Presentation
 
Dendreon Strategic Analysis
Dendreon Strategic AnalysisDendreon Strategic Analysis
Dendreon Strategic Analysis
 
Roche & Alexion M&A Simulation
Roche & Alexion M&A SimulationRoche & Alexion M&A Simulation
Roche & Alexion M&A Simulation
 
Bio Pharm Collaborations 9 09
Bio Pharm Collaborations 9 09Bio Pharm Collaborations 9 09
Bio Pharm Collaborations 9 09
 
The Role of clinical Research in Pharmaceuticals Industry
The Role of clinical Research in Pharmaceuticals IndustryThe Role of clinical Research in Pharmaceuticals Industry
The Role of clinical Research in Pharmaceuticals Industry
 
New England Compounding Center and Microbial Contamination ASQ Presentation
New England Compounding Center and Microbial Contamination ASQ PresentationNew England Compounding Center and Microbial Contamination ASQ Presentation
New England Compounding Center and Microbial Contamination ASQ Presentation
 
Eyf webinar sepa career fair 2010
Eyf webinar sepa career fair 2010Eyf webinar sepa career fair 2010
Eyf webinar sepa career fair 2010
 
pharmaceutical-industry-r-d-an-inside-out-look.ppt
pharmaceutical-industry-r-d-an-inside-out-look.pptpharmaceutical-industry-r-d-an-inside-out-look.ppt
pharmaceutical-industry-r-d-an-inside-out-look.ppt
 
Pharmaceutical Industry - Business Perspectives for IT Teams
Pharmaceutical Industry - Business Perspectives for IT TeamsPharmaceutical Industry - Business Perspectives for IT Teams
Pharmaceutical Industry - Business Perspectives for IT Teams
 
Pharma Focus Asia Issue 21
Pharma Focus Asia Issue 21Pharma Focus Asia Issue 21
Pharma Focus Asia Issue 21
 
Genentech
GenentechGenentech
Genentech
 
BioEntrepreneurship: Life Science Business Models
BioEntrepreneurship: Life Science Business ModelsBioEntrepreneurship: Life Science Business Models
BioEntrepreneurship: Life Science Business Models
 
Focus On Brazil 1.7
Focus On Brazil 1.7Focus On Brazil 1.7
Focus On Brazil 1.7
 
Focus On Brazil 1.8
Focus On Brazil 1.8Focus On Brazil 1.8
Focus On Brazil 1.8
 
Eli Lilly and company - Drug Development Strategy
Eli Lilly and company - Drug Development StrategyEli Lilly and company - Drug Development Strategy
Eli Lilly and company - Drug Development Strategy
 
Aiden hollis hif presentation berkeley
Aiden hollis   hif presentation berkeleyAiden hollis   hif presentation berkeley
Aiden hollis hif presentation berkeley
 
What's In An Idea-Chanda-UofT Life Science Coach
What's In An Idea-Chanda-UofT Life Science CoachWhat's In An Idea-Chanda-UofT Life Science Coach
What's In An Idea-Chanda-UofT Life Science Coach
 

More from thinkBiotech

Defeating COVID-19
Defeating COVID-19Defeating COVID-19
Defeating COVID-19
thinkBiotech
 
Evaluating innovative portfolios and preparing for branded, 505(b)(2), and ge...
Evaluating innovative portfolios and preparing for branded, 505(b)(2), and ge...Evaluating innovative portfolios and preparing for branded, 505(b)(2), and ge...
Evaluating innovative portfolios and preparing for branded, 505(b)(2), and ge...
thinkBiotech
 
Finding and evaluating branded and generic market entry opportunities
Finding and evaluating branded and generic market entry opportunitiesFinding and evaluating branded and generic market entry opportunities
Finding and evaluating branded and generic market entry opportunities
thinkBiotech
 
When do drug patents expire and when can generic drugs launch?
When do drug patents expire and when can generic drugs launch?When do drug patents expire and when can generic drugs launch?
When do drug patents expire and when can generic drugs launch?
thinkBiotech
 
Educating the Next Generation of Biotechnology Managers and Founders
Educating the Next Generation of Biotechnology Managers and FoundersEducating the Next Generation of Biotechnology Managers and Founders
Educating the Next Generation of Biotechnology Managers and Founders
thinkBiotech
 
Innovating Across Borders
Innovating Across BordersInnovating Across Borders
Innovating Across Borders
thinkBiotech
 

More from thinkBiotech (6)

Defeating COVID-19
Defeating COVID-19Defeating COVID-19
Defeating COVID-19
 
Evaluating innovative portfolios and preparing for branded, 505(b)(2), and ge...
Evaluating innovative portfolios and preparing for branded, 505(b)(2), and ge...Evaluating innovative portfolios and preparing for branded, 505(b)(2), and ge...
Evaluating innovative portfolios and preparing for branded, 505(b)(2), and ge...
 
Finding and evaluating branded and generic market entry opportunities
Finding and evaluating branded and generic market entry opportunitiesFinding and evaluating branded and generic market entry opportunities
Finding and evaluating branded and generic market entry opportunities
 
When do drug patents expire and when can generic drugs launch?
When do drug patents expire and when can generic drugs launch?When do drug patents expire and when can generic drugs launch?
When do drug patents expire and when can generic drugs launch?
 
Educating the Next Generation of Biotechnology Managers and Founders
Educating the Next Generation of Biotechnology Managers and FoundersEducating the Next Generation of Biotechnology Managers and Founders
Educating the Next Generation of Biotechnology Managers and Founders
 
Innovating Across Borders
Innovating Across BordersInnovating Across Borders
Innovating Across Borders
 

Recently uploaded

Brand Analysis for an artist named Struan
Brand Analysis for an artist named StruanBrand Analysis for an artist named Struan
Brand Analysis for an artist named Struan
sarahvanessa51503
 
RMD24 | Debunking the non-endemic revenue myth Marvin Vacquier Droop | First ...
RMD24 | Debunking the non-endemic revenue myth Marvin Vacquier Droop | First ...RMD24 | Debunking the non-endemic revenue myth Marvin Vacquier Droop | First ...
RMD24 | Debunking the non-endemic revenue myth Marvin Vacquier Droop | First ...
BBPMedia1
 
The Influence of Marketing Strategy and Market Competition on Business Perfor...
The Influence of Marketing Strategy and Market Competition on Business Perfor...The Influence of Marketing Strategy and Market Competition on Business Perfor...
The Influence of Marketing Strategy and Market Competition on Business Perfor...
Adam Smith
 
What are the main advantages of using HR recruiter services.pdf
What are the main advantages of using HR recruiter services.pdfWhat are the main advantages of using HR recruiter services.pdf
What are the main advantages of using HR recruiter services.pdf
HumanResourceDimensi1
 
Business Valuation Principles for Entrepreneurs
Business Valuation Principles for EntrepreneursBusiness Valuation Principles for Entrepreneurs
Business Valuation Principles for Entrepreneurs
Ben Wann
 
Introduction to Amazon company 111111111111
Introduction to Amazon company 111111111111Introduction to Amazon company 111111111111
Introduction to Amazon company 111111111111
zoyaansari11365
 
Unveiling the Secrets How Does Generative AI Work.pdf
Unveiling the Secrets How Does Generative AI Work.pdfUnveiling the Secrets How Does Generative AI Work.pdf
Unveiling the Secrets How Does Generative AI Work.pdf
Sam H
 
LA HUG - Video Testimonials with Chynna Morgan - June 2024
LA HUG - Video Testimonials with Chynna Morgan - June 2024LA HUG - Video Testimonials with Chynna Morgan - June 2024
LA HUG - Video Testimonials with Chynna Morgan - June 2024
Lital Barkan
 
Sustainability: Balancing the Environment, Equity & Economy
Sustainability: Balancing the Environment, Equity & EconomySustainability: Balancing the Environment, Equity & Economy
Sustainability: Balancing the Environment, Equity & Economy
Operational Excellence Consulting
 
一比一原版加拿大渥太华大学毕业证(uottawa毕业证书)如何办理
一比一原版加拿大渥太华大学毕业证(uottawa毕业证书)如何办理一比一原版加拿大渥太华大学毕业证(uottawa毕业证书)如何办理
一比一原版加拿大渥太华大学毕业证(uottawa毕业证书)如何办理
taqyed
 
Cracking the Workplace Discipline Code Main.pptx
Cracking the Workplace Discipline Code Main.pptxCracking the Workplace Discipline Code Main.pptx
Cracking the Workplace Discipline Code Main.pptx
Workforce Group
 
ikea_woodgreen_petscharity_dog-alogue_digital.pdf
ikea_woodgreen_petscharity_dog-alogue_digital.pdfikea_woodgreen_petscharity_dog-alogue_digital.pdf
ikea_woodgreen_petscharity_dog-alogue_digital.pdf
agatadrynko
 
The effects of customers service quality and online reviews on customer loyal...
The effects of customers service quality and online reviews on customer loyal...The effects of customers service quality and online reviews on customer loyal...
The effects of customers service quality and online reviews on customer loyal...
balatucanapplelovely
 
Digital Transformation and IT Strategy Toolkit and Templates
Digital Transformation and IT Strategy Toolkit and TemplatesDigital Transformation and IT Strategy Toolkit and Templates
Digital Transformation and IT Strategy Toolkit and Templates
Aurelien Domont, MBA
 
ENTREPRENEURSHIP TRAINING.ppt for graduating class (1).ppt
ENTREPRENEURSHIP TRAINING.ppt for graduating class (1).pptENTREPRENEURSHIP TRAINING.ppt for graduating class (1).ppt
ENTREPRENEURSHIP TRAINING.ppt for graduating class (1).ppt
zechu97
 
ModelingMarketingStrategiesMKS.CollumbiaUniversitypdf
ModelingMarketingStrategiesMKS.CollumbiaUniversitypdfModelingMarketingStrategiesMKS.CollumbiaUniversitypdf
ModelingMarketingStrategiesMKS.CollumbiaUniversitypdf
fisherameliaisabella
 
Memorandum Of Association Constitution of Company.ppt
Memorandum Of Association Constitution of Company.pptMemorandum Of Association Constitution of Company.ppt
Memorandum Of Association Constitution of Company.ppt
seri bangash
 
Exploring Patterns of Connection with Social Dreaming
Exploring Patterns of Connection with Social DreamingExploring Patterns of Connection with Social Dreaming
Exploring Patterns of Connection with Social Dreaming
Nicola Wreford-Howard
 
What is the TDS Return Filing Due Date for FY 2024-25.pdf
What is the TDS Return Filing Due Date for FY 2024-25.pdfWhat is the TDS Return Filing Due Date for FY 2024-25.pdf
What is the TDS Return Filing Due Date for FY 2024-25.pdf
seoforlegalpillers
 
Meas_Dylan_DMBS_PB1_2024-05XX_Revised.pdf
Meas_Dylan_DMBS_PB1_2024-05XX_Revised.pdfMeas_Dylan_DMBS_PB1_2024-05XX_Revised.pdf
Meas_Dylan_DMBS_PB1_2024-05XX_Revised.pdf
dylandmeas
 

Recently uploaded (20)

Brand Analysis for an artist named Struan
Brand Analysis for an artist named StruanBrand Analysis for an artist named Struan
Brand Analysis for an artist named Struan
 
RMD24 | Debunking the non-endemic revenue myth Marvin Vacquier Droop | First ...
RMD24 | Debunking the non-endemic revenue myth Marvin Vacquier Droop | First ...RMD24 | Debunking the non-endemic revenue myth Marvin Vacquier Droop | First ...
RMD24 | Debunking the non-endemic revenue myth Marvin Vacquier Droop | First ...
 
The Influence of Marketing Strategy and Market Competition on Business Perfor...
The Influence of Marketing Strategy and Market Competition on Business Perfor...The Influence of Marketing Strategy and Market Competition on Business Perfor...
The Influence of Marketing Strategy and Market Competition on Business Perfor...
 
What are the main advantages of using HR recruiter services.pdf
What are the main advantages of using HR recruiter services.pdfWhat are the main advantages of using HR recruiter services.pdf
What are the main advantages of using HR recruiter services.pdf
 
Business Valuation Principles for Entrepreneurs
Business Valuation Principles for EntrepreneursBusiness Valuation Principles for Entrepreneurs
Business Valuation Principles for Entrepreneurs
 
Introduction to Amazon company 111111111111
Introduction to Amazon company 111111111111Introduction to Amazon company 111111111111
Introduction to Amazon company 111111111111
 
Unveiling the Secrets How Does Generative AI Work.pdf
Unveiling the Secrets How Does Generative AI Work.pdfUnveiling the Secrets How Does Generative AI Work.pdf
Unveiling the Secrets How Does Generative AI Work.pdf
 
LA HUG - Video Testimonials with Chynna Morgan - June 2024
LA HUG - Video Testimonials with Chynna Morgan - June 2024LA HUG - Video Testimonials with Chynna Morgan - June 2024
LA HUG - Video Testimonials with Chynna Morgan - June 2024
 
Sustainability: Balancing the Environment, Equity & Economy
Sustainability: Balancing the Environment, Equity & EconomySustainability: Balancing the Environment, Equity & Economy
Sustainability: Balancing the Environment, Equity & Economy
 
一比一原版加拿大渥太华大学毕业证(uottawa毕业证书)如何办理
一比一原版加拿大渥太华大学毕业证(uottawa毕业证书)如何办理一比一原版加拿大渥太华大学毕业证(uottawa毕业证书)如何办理
一比一原版加拿大渥太华大学毕业证(uottawa毕业证书)如何办理
 
Cracking the Workplace Discipline Code Main.pptx
Cracking the Workplace Discipline Code Main.pptxCracking the Workplace Discipline Code Main.pptx
Cracking the Workplace Discipline Code Main.pptx
 
ikea_woodgreen_petscharity_dog-alogue_digital.pdf
ikea_woodgreen_petscharity_dog-alogue_digital.pdfikea_woodgreen_petscharity_dog-alogue_digital.pdf
ikea_woodgreen_petscharity_dog-alogue_digital.pdf
 
The effects of customers service quality and online reviews on customer loyal...
The effects of customers service quality and online reviews on customer loyal...The effects of customers service quality and online reviews on customer loyal...
The effects of customers service quality and online reviews on customer loyal...
 
Digital Transformation and IT Strategy Toolkit and Templates
Digital Transformation and IT Strategy Toolkit and TemplatesDigital Transformation and IT Strategy Toolkit and Templates
Digital Transformation and IT Strategy Toolkit and Templates
 
ENTREPRENEURSHIP TRAINING.ppt for graduating class (1).ppt
ENTREPRENEURSHIP TRAINING.ppt for graduating class (1).pptENTREPRENEURSHIP TRAINING.ppt for graduating class (1).ppt
ENTREPRENEURSHIP TRAINING.ppt for graduating class (1).ppt
 
ModelingMarketingStrategiesMKS.CollumbiaUniversitypdf
ModelingMarketingStrategiesMKS.CollumbiaUniversitypdfModelingMarketingStrategiesMKS.CollumbiaUniversitypdf
ModelingMarketingStrategiesMKS.CollumbiaUniversitypdf
 
Memorandum Of Association Constitution of Company.ppt
Memorandum Of Association Constitution of Company.pptMemorandum Of Association Constitution of Company.ppt
Memorandum Of Association Constitution of Company.ppt
 
Exploring Patterns of Connection with Social Dreaming
Exploring Patterns of Connection with Social DreamingExploring Patterns of Connection with Social Dreaming
Exploring Patterns of Connection with Social Dreaming
 
What is the TDS Return Filing Due Date for FY 2024-25.pdf
What is the TDS Return Filing Due Date for FY 2024-25.pdfWhat is the TDS Return Filing Due Date for FY 2024-25.pdf
What is the TDS Return Filing Due Date for FY 2024-25.pdf
 
Meas_Dylan_DMBS_PB1_2024-05XX_Revised.pdf
Meas_Dylan_DMBS_PB1_2024-05XX_Revised.pdfMeas_Dylan_DMBS_PB1_2024-05XX_Revised.pdf
Meas_Dylan_DMBS_PB1_2024-05XX_Revised.pdf
 

Beyond the Business Plan - Managing unexpected risks in biotechnology business development